Monopar Therapeutics (MNPR) Other Non-Current Assets (2016 - 2021)
Monopar Therapeutics (MNPR) reported Other Non-Current Assets of $68858.0 for Q3 2021, little changed on a YoY basis from $68858.0 in Q3 2020, and little changed sequentially from $68858.0 in Q2 2021.
Monopar Therapeutics (MNPR) Other Non-Current Assets (2016 - 2021) Analysis & Trends
Monopar Therapeutics (MNPR) has 6 years of Other Non-Current Assets data on file, last reported at $68858.0 in Q3 2021.
- For the quarter ending Q3 2021, Other Non-Current Assets changed 0.0% year-over-year to $68858.0; the trailing twelve-month figure through Sep 2021 stood at $68858.0 (changed 0.0% YoY), and the FY2020 full-year result was $68858.0, down 43.73% from the prior year.
- Other Non-Current Assets was little changed at $68858.0 in Q3 2021, from $68858.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $800031.0 in Q4 2017 to a low of $65731.0 in Q4 2018.
- A 5-year average of $260660.5 and a median of $70954.0 in 2020 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets slumped 91.78% in 2018 and surged 86.18% in 2019, its largest moves.
- Tracing MNPR's Other Non-Current Assets over 5 years: stood at $800031.0 in 2017, then tumbled by 91.78% to $65731.0 in 2018, then surged by 86.18% to $122381.0 in 2019, then sank by 43.73% to $68858.0 in 2020, then changed by 0.0% to $68858.0 in 2021.
- Business Quant data shows MNPR's Other Non-Current Assets at $68858.0 in Q3 2021, $68858.0 in Q2 2021, and $68858.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Monopar Therapeutics | 707.36 Mn | 645.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 68,858.00 |
| Jun 30, 2021 | 68,858.00 |
| Mar 31, 2021 | 68,858.00 |
| Dec 31, 2020 | 68,858.00 |
| Sep 30, 2020 | 68,858.00 |
| Jun 30, 2020 | 73,050.00 |
| Mar 31, 2020 | 122,381.00 |
| Dec 31, 2019 | 122,381.00 |
| Dec 31, 2018 | 65,731.00 |
| Jun 30, 2018 | 800,031.00 |
| Mar 31, 2018 | 800,031.00 |
| Dec 31, 2017 | 800,031.00 |
| Dec 31, 2016 | 800,393.00 |